Merck, Gilead Update Phase 3 KEYNOTE-D46/EVOKE-03 Study Final
09 Jun 2026 //
PRESS RELEASE
GSK Discusses Acquisition Of Cancer Biotech Nuvalent For Over $9B
09 Jun 2026 //
REUTERS
Lupin Manufacturing Solutions Names Eduardo Jule Chief
09 Jun 2026 //
INDPHARMAPOST
US FDA Approves Pfizer's Bleeding Disorder Drug For Children
09 Jun 2026 //
PRESS RELEASE
Sanofi Sarclisa Wins EU Nod as First On-Body Injector
09 Jun 2026 //
GLOBENEWSWIRE
RevMed & Tango's Pancreatic Cancer Combo Achieves 92% Response
09 Jun 2026 //
REUTERS
J&J Bets $1B Upfront on Emerging DAC Space With Firefly Bio
09 Jun 2026 //
REUTERS
Roche Invests $3B In Nurix's Blood Cancer Protein Degrader
09 Jun 2026 //
GLOBENEWSWIRE
Kunwar Khurana elevated to Head – Sales and Marketing
09 Jun 2026 //
INDPHARMAPOST
Congo Says Ebola Deaths Top 100 As Armed Groups Threaten Response
08 Jun 2026 //
REUTERS
Takeda Faces $2.5B Hit from Amitiza Antitrust Verdict
08 Jun 2026 //
ENDPOINTS
India's GLP-1 Market Cools After Initial Semaglutide Surge
08 Jun 2026 //
BUSINESS STD
Maiva Pharma Opens Sterile Injectables Plant in Tamil Nadu
08 Jun 2026 //
INDPHARMAPOST
Federal Circuit Affirms Cormedix Patent Victory in Minocin Case
08 Jun 2026 //
GLOBENEWSWIRE
Alembic Pharma Receives FDA Approval for Haloperidol Tablets
06 Jun 2026 //
INDPHARMAPOST
Glenmark Enters U.S. Market with Generic Lacosamide Injection
05 Jun 2026 //
INDPHARMAPOST
Aurobindo Pharma Gets USFDA Nod for Generic Tofacitinib Tablets
05 Jun 2026 //
INDPHARMAPOST
Breckenridge Launches Tofacitinib Tablets, Generic of Xeljanz®
04 Jun 2026 //
PRESS RELEASE
Amneal Receives FDA Approval for Romidepsin Injection Solution
04 Jun 2026 //
GLOBENEWSWIRE
India's Regulatory Landscape Becoming More Globally Aligned
04 Jun 2026 //
EXPRESSPHARMA
Merck, Gilead Update Phase 3 KEYNOTE-D46/EVOKE-03 Study Final
09 Jun 2026 //
PRESS RELEASE
GSK Discusses Acquisition Of Cancer Biotech Nuvalent For Over $9B
09 Jun 2026 //
REUTERS
US FDA Approves Pfizer's Bleeding Disorder Drug For Children
09 Jun 2026 //
PRESS RELEASE
Sanofi Sarclisa Wins EU Nod as First On-Body Injector
09 Jun 2026 //
GLOBENEWSWIRE
RevMed & Tango's Pancreatic Cancer Combo Achieves 92% Response
09 Jun 2026 //
REUTERS
J&J Bets $1B Upfront on Emerging DAC Space With Firefly Bio
09 Jun 2026 //
REUTERS
Roche Invests $3B In Nurix's Blood Cancer Protein Degrader
09 Jun 2026 //
GLOBENEWSWIRE
Cavalry Biosciences Targets $75M Series B for Eye, Muscle Drugs
08 Jun 2026 //
ENDPOINTS
Regentis Starts EU Surgeon Training for GelrinC in Knee Repair
08 Jun 2026 //
ACCESSWIRE
Diabetology's Breakthrough Data From Oraglutide Oral GLP-1
08 Jun 2026 //
BUSINESSWIRE
CBC India & Metalco-Alupack sign exclusive strategic partnership
08 Jun 2026 //
EXPRESSPHARMA
TDB Supports Indigenous Production of Green Pharma Ingredients
04 Jun 2026 //
INDPHARMAPOST
PharmaBlock's First Peptide GMP Pilot Plant Now Operational
04 Jun 2026 //
PR NEWSWIRE
Niner Pharma Expands Global Peptide and Oncology API Network
03 Jun 2026 //
FIRSTWORD PHARMA
Intracin Pharma Gets Australian APVMA Approval for Vet Medicines
03 Jun 2026 //
INDPHARMAPOST
Strategic API Sourcing: Building Supply Chain Resilience
02 Jun 2026 //
PRESS RELEASE
NPPA Revises Injectable Antibiotic Price Ceiling Following Review
02 Jun 2026 //
PHARMABIZ
The Power of Micronization in Small Molecule APIs
02 Jun 2026 //
PRESS RELEASE
India-Oman CEPA Kicks Off June 1 with Zero Pharma Tariffs
30 May 2026 //
PHARMABIZ
Wockhardt Gets CDSCO Nod for Zaynich Antibiotic
28 May 2026 //
ECONOMICTIMES
CDSCO Seeks State Action Data on Antibiotics Banned in Farming
08 Jun 2026 //
PHARMABIZ
Drug Samples from Major Pharma Companies Fail Quality Tests
08 Jun 2026 //
PHARMABIZ
BDCDA Warns of Improper Disposal of Expired Drugs & Medical Waste
06 Jun 2026 //
PHARMABIZ
Telangana Cracks Down on Illegal Medical Practice in Hanamkonda
06 Jun 2026 //
PHARMABIZ
CDSCO Logs 1,387 Adverse Drug Reaction Reports in 9Months of 2025
05 Jun 2026 //
PHARMABIZ
DCGI Demands Strict Revised Schedule M Compliance at Pharmac Expo
05 Jun 2026 //
PHARMABIZ
CDSCO Orders All Stakeholders to Set Up Pharmacovigilance Systems
05 Jun 2026 //
PHARMABIZ
FDA Issues Warning to Drugmaker for Misleading Email Promotion
05 Jun 2026 //
RAPS
Teva UK Issues Class 4 Defect Notification for Ponlimsi Denosumab
04 Jun 2026 //
PRESS RELEASE
ADC Therapeutics' Shares Plummet After Patient Deaths in Trial
04 Jun 2026 //
FIERCE PHARMA
Congo Says Ebola Deaths Top 100 As Armed Groups Threaten Response
08 Jun 2026 //
REUTERS
Industry Groups Seek More Flexibility For DHTs In Clinical Trials
08 Jun 2026 //
RAPS
Japan PMDA Issues Guidance on Monoclonal Antibody Toxicity Assess
08 Jun 2026 //
RAPS
NGD Launches NGD200 Automated Bacterial Sample Prep for Hospitals
08 Jun 2026 //
ACCESSWIRE
Ceribell Links Clarity AI Seizure Burden to Neurological Outcomes
08 Jun 2026 //
GLOBENEWSWIRE
Vantive Shows HDx as Practical Alternative to Online HDF at ERA
08 Jun 2026 //
GLOBENEWSWIRE
Sequel Presents twiist AID System Pivotal T2D Trial Data at ADA
08 Jun 2026 //
GLOBENEWSWIRE
ICH Adopts GCP Annex 2, Announces Progress On Other Guidelines
08 Jun 2026 //
RAPS
Enovis Launches Spinamic Hybrid Scoliosis Brace for Pediatrics
08 Jun 2026 //
GLOBENEWSWIRE
Conexeu Reports Manufacturing and Regulatory Progress for CXU
08 Jun 2026 //
GLOBENEWSWIRE
Post-Makary, New Rare Disease Framework Faces Fresh Uncertainty
08 Jun 2026 //
BIOSPACE
Busy FDA: Complementary Pathways Despite Unanswered Questions
08 Jun 2026 //
BIOSPACE
Zevra Therapeutics Lists Patent to Protect MIPLYFFA Exclusivity
08 Jun 2026 //
GLOBENEWSWIRE
Alkeus Doses First Patient in Phase 3 Gildeuretinol Study
08 Jun 2026 //
GLOBENEWSWIRE
Teva Showcases AUSTEDO Long-Term Advances in Tardive Dyskinesia
08 Jun 2026 //
GLOBENEWSWIRE
Spruce Shows Long-Term Tralesinidase Alfa ERT Data in MPS IIIB
08 Jun 2026 //
BUSINESSWIRE
Neurogene Completes Dosing in NGN-401 Rett Syndrome Trial
08 Jun 2026 //
BUSINESSWIRE
Neurocrine Highlights INGREZZA Efficacy in Tardive Dyskinesia
08 Jun 2026 //
PR NEWSWIRE
NanoViricides Proposes Phase 2 Oral Ebola Treatment Trial
08 Jun 2026 //
ACCESSWIRE
Ascendis to Highlight Rare Endocrine Disease Progress at ENDO'26
08 Jun 2026 //
GLOBENEWSWIRE
Lupin Manufacturing Solutions Names Eduardo Jule Chief
09 Jun 2026 //
INDPHARMAPOST
Kunwar Khurana elevated to Head – Sales and Marketing
09 Jun 2026 //
INDPHARMAPOST
Aclarion Rejects Lake Capital's Unsolicited Acquisition Proposal
08 Jun 2026 //
GLOBENEWSWIRE
Hexiris Ophthalmics Debuts Dry Lab and Milestones at COS Meeting
08 Jun 2026 //
GLOBENEWSWIRE
Hoag Named California's First Endometriosis Center of Excellence
08 Jun 2026 //
GLOBENEWSWIRE
Aclarion Shareholders Approve All 2026 Annual Meeting Proposals
08 Jun 2026 //
GLOBENEWSWIRE
Smile Foundation Delivers 20 Lakh Healthcare Treatments In FY26
08 Jun 2026 //
INDPHARMAPOST
Vanna Health Names Dr. Liz Kwo CEO, Colella Executive Chairman
08 Jun 2026 //
ACCESSWIRE
Hyperion Defi Confirms USDH And Felix Markets Sunset Guidance
08 Jun 2026 //
GLOBENEWSWIRE
Lakefront Appoints Eric Hedrick, MD, As Chief Medical Officer
08 Jun 2026 //
GLOBENEWSWIRE
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.